封面
市场调查报告书
商品编码
1452837

全球湿性伤口敷料市场规模、份额和成长分析:按产品、应用和最终用户 - 产业预测(2024-2031)

Global Moist Wound Dressings Market Size, Share, Growth Analysis, By Product(Foams, Hydrocolloids), By Application(Pressure Ulcers, Diabetic Ulcers), By End-user(Hospitals, Homecare) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球湿性伤口敷料市场规模预计2022年为43.1亿美元,从2023年的45.3亿美元增长到2031年的68亿美元,预计将从2023年的45.3亿美元增长到2031年的68亿美元。2031 亿美元)复合年增长率为5.2%。

由于对先进创伤护理的日益关注以及糖尿病溃疡和压疮等慢性伤口数量的迅速增加,全球湿性伤口敷料市场呈现强劲增长。湿性伤口敷料越来越多地被医疗保健专业人员采用,因为它们可以促进最佳的癒合环境、预防感染并加速伤口癒合。这些敷料具有增强保湿性、减少疼痛和提高患者舒适度等优点。此外,研究和开发不断透过创新材料和技术提高湿性伤口敷料的有效性。随着全球人口老化的不断加剧和医疗保健基础设施的进步,对高效伤口管理解决方案的需求预计将在短期内推动市场成长。

目录

执行摘要

  • 市场概况
  • 命运之轮

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管环境
  • 波特的分析
  • 对未来中断的特殊考虑

全球湿润伤口敷料市场:依产品

  • 市场概况
  • 形式
  • 亲水胶体
  • 半透膜
  • 水凝胶
  • 藻酸盐
  • 亲水性纤维敷料胶原蛋白

全球湿性伤口敷料市场:依应用分类

  • 市场概况
  • 褥疮
  • 糖尿病溃疡
  • 烧烫伤
  • 手术伤口
  • 外伤
  • 其他的

全球湿润伤口敷料市场:依最终用户分类

  • 市场概况
  • 医院
  • 居家护理
  • 诊所
  • 其他的

全球湿性伤口敷料市场规模(按地区划分)

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • 3M Healthcare(US)
  • Coloplast A/S(Denmark)
  • Medline Industries, Inc.(US)
  • Cardinal Health, Inc.(US)
  • B. Braun Melsungen AG(Germany)
  • Smith & Nephew PLC(UK)
  • ConvaTec Group PLC(UK)
  • Derma Sciences, Inc.(US)
  • Systagenix Wound Management Ltd(UK)
  • Molnlycke Health Care AB(Sweden)
  • Johnson & Johnson(US)
  • Hollister Incorporated(US)
  • Ethicon, Inc.(US)
  • Acelity LP Inc.(US)
  • Advancis Medical(UK)
  • Coloplast Corporation(US)
  • Medtronic plc(Ireland)
  • Molnlycke Health Care(US)
  • Urgo Medical(France)
  • Medline Industries Ltd.(UK)
  • In May 2023, Kane Biotech Inc.(referred to as Kane Biotech)announced that it had gotten 510(k)freedom from the US Food, Drug Administration(FDA)for its coactiv+(TM)Antimicrobial Injury Gel. This clearance covers the management of ulcers(counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds,, and careful entry points for grown-up populaces.
  • In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM)Antimicrobial Injury Gel(previously known as coactiv+(TM)Antimicrobial Injury Gel).
简介目录
Product Code: SQMIG35D2162

Global Moist Wound Dressings market size was valued at USD 4.31 billion in 2022 and is poised to grow from USD 4.53 billion in 2023 to USD 6.80 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).

The global market for moist wound dressings demonstrates robust growth, propelled by the rising focus on advanced wound care and the escalating prevalence of chronic wounds like diabetic ulcers and pressure sores. Healthcare professionals are increasingly embracing moist wound dressings due to their capacity to foster an optimal healing environment, prevent infections, and expedite wound recovery. These dressings offer benefits such as enhanced moisture retention, reduced pain, and improved patient comfort. Furthermore, ongoing research and development endeavors are dedicated to enhancing the effectiveness of moist wound dressings through innovative materials and technologies. With the aging population expanding and healthcare infrastructure advancing globally, the demand for efficient wound management solutions is anticipated to drive the market's growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Moist Wound Dressings Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Moist Wound Dressings Market Segmental Analysis

The global moist wound dressings market is segmented on the basis of Product, Application, End user, and region. By Product, the market is segmented into Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Other Dressings. By Application, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical and Traumatic Wounds, Burns, Others. By End user, the market is segmented into Hospitals, Clinics, Home Healthcare. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Moist Wound Dressings Market

A significant factor driving the global moist wound dressings market is the ongoing progress in wound care technologies and materials. Developments in dressing materials, including hydrocolloids, hydrogels, and foam dressings, have resulted in more efficient and adaptable products that foster optimal wound healing environments. Moreover, the incorporation of antimicrobial agents and the creation of smart dressings capable of monitoring wound conditions are enhancing the therapeutic properties of moist wound dressings. These advancements are leading to increased adoption by healthcare professionals and patients, thereby stimulating market growth.

Restraints in the Global Moist Wound Dressings Market

A significant constraint in the global moist wound dressings market is the stringent regulatory landscape governing medical devices and healthcare products. Adhering to diverse regulatory requirements and securing necessary approvals can be a laborious and expensive endeavor for manufacturers. Moreover, evolving regulations and differing standards across various regions can present hurdles for market expansion and product advancement. Negotiating these regulatory obstacles can slow down the pace of innovation and market entry for moist wound dressing products.

Market Trends of the Global Moist Wound Dressings Market

A significant trend in the global moist wound dressings market is the growing focus on integrating bioactive ingredients into these dressings. Manufacturers are exploring the inclusion of substances such as silver, honey, and growth factors to enhance the therapeutic properties of the dressings. These bioactive additives hold promise in expediting wound healing, lowering infection rates, and enhancing overall patient outcomes. As healthcare providers and patients increasingly seek more efficient and comprehensive wound care solutions, moist dressings with bioactive elements are gaining momentum, signaling a noteworthy transition towards advanced and tailored wound management approaches.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Moist Wound Dressings Market by Product

  • Market Overview
  • Foams
  • Hydrocolloids
  • Semi-Permeable Films
  • Hydrogels
  • Alginates
  • Hydro Fibres and Collagens

Global Moist Wound Dressings Market by Application

  • Market Overview
  • Pressure Ulcers
  • Diabetic Ulcers
  • Burn Wounds
  • Surgical Wounds
  • Traumatic Wounds
  • and Others

Global Moist Wound Dressings Market by End-user

  • Market Overview
  • Hospitals
  • Homecare
  • Clinics
  • and Others

Global Moist Wound Dressings Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • 3M Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Derma Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systagenix Wound Management Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acelity L.P. Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advancis Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urgo Medical (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In May 2023, Kane Biotech Inc. (referred to as Kane Biotech) announced that it had gotten 510(k) freedom from the U.S. Food and Drug Administration (FDA) for its coactiv+(TM) Antimicrobial Injury Gel. This clearance covers the management of ulcers (counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds, and careful entry points for grown-up populaces.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM) Antimicrobial Injury Gel (previously known as coactiv+(TM) Antimicrobial Injury Gel).
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments